Department of Physiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan ; Advanced Research Training Program, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Neoplasia. 2013 Nov;15(11):1272-81. doi: 10.1593/neo.131440.
Microenvironmental conditions such as hypoxia potentiate the local invasion of malignant tumors including glioblastomas by modulating signal transduction and protein modification, yet the mechanism by which hypoxia controls cytoskeletal dynamics to promote the local invasion is not well defined. Here, we show that cyclin G2 plays pivotal roles in the cytoskeletal dynamics in hypoxia-driven invasion by glioblastoma cells. Cyclin G2 is a hypoxia-induced and cytoskeleton-associated protein and is required for glioblastoma expansion. Mechanistically, cyclin G2 recruits cortactin to the juxtamembrane through its SH3 domain-binding motif and consequently promotes the restricted tyrosine phosphorylation of cortactin in concert with src. Moreover, cyclin G2 interacts with filamentous actin to facilitate the formation of membrane ruffles. In primary glioblastoma, cyclin G2 is abundantly expressed in severely hypoxic regions such as pseudopalisades, which consist of actively migrating glioma cells. Furthermore, we show the effectiveness of dasatinib against hypoxia-driven, cyclin G2-involved invasion in vitro and in vivo. Our findings elucidate the mechanism of cytoskeletal regulation by which severe hypoxia promotes the local invasion and may provide a therapeutic target in glioblastoma.
微环境条件,如缺氧,通过调节信号转导和蛋白质修饰,增强包括神经胶质瘤在内的恶性肿瘤的局部侵袭,然而,缺氧控制细胞骨架动力学以促进局部侵袭的机制尚未完全明确。在这里,我们表明细胞周期蛋白 G2 在缺氧驱动的神经胶质瘤细胞侵袭的细胞骨架动力学中发挥关键作用。细胞周期蛋白 G2 是一种缺氧诱导的细胞骨架相关蛋白,是神经胶质瘤扩张所必需的。在机制上,细胞周期蛋白 G2 通过其 SH3 结构域结合基序将 cortactin 募集到质膜附近,从而促进 src 协同下 cortactin 的受限酪氨酸磷酸化。此外,细胞周期蛋白 G2 与丝状肌动蛋白相互作用,促进膜皱襞的形成。在原发性神经胶质瘤中,细胞周期蛋白 G2 在富含细胞的缺氧区域(如假足)中大量表达,这些区域由活跃迁移的神经胶质瘤细胞组成。此外,我们还展示了达沙替尼在体外和体内抑制缺氧驱动的、细胞周期蛋白 G2 参与的侵袭的有效性。我们的研究结果阐明了严重缺氧促进局部侵袭的细胞骨架调节机制,并可能为神经胶质瘤提供一个治疗靶点。